AI assistant
NEKTAR THERAPEUTICS — Director's Dealing 2017
Mar 4, 2017
32134_dirs_2017-03-03_b72cbb56-5707-43dd-92ac-ccbf559e373e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-03-02
Reporting Person: Labrucherie Gil M (SVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-02 | Common Stock | M | 167506 | $6.34 | Acquired | 236776 | Direct |
| 2017-03-02 | Common Stock | S | 167506 | $15.15 | Disposed | 69270 | Direct |
| 2017-03-03 | Common Stock | M | 7494 | $6.34 | Acquired | 76764 | Direct |
| 2017-03-03 | Common Stock | S | 7494 | $15.21 | Disposed | 69270 | Direct |
| 2017-03-03 | Common Stock | M | 25000 | $9.24 | Acquired | 94270 | Direct |
| 2017-03-03 | Common Stock | S | 25000 | $15.21 | Disposed | 69270 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-02 | Stock Option | $6.34 | M | 167506 | Disposed | 2017-06-09 | Common Stock (167506) | Direct |
| 2017-03-03 | Stock Option | $6.34 | M | 7494 | Disposed | 2017-06-09 | Common Stock (7494) | Direct |
| 2017-03-03 | Stock Option | $9.24 | M | 25000 | Disposed | 2017-11-17 | Common Stock (25000) | Direct |
Footnotes
F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017.
F2: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
F3: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F4: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F5: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 25,000 stock options scheduled to expire on November 17, 2017.